Institutional shares held 284 Million
1.36M calls
1.62M puts
Total value of holdings $113B
$538M calls
$642M puts
Market Cap $150B
378,320,992 Shares Out.
Institutional ownership 75.08%
# of Institutions 2,288


Latest Institutional Activity in SYK

Top Purchases

Q4 2024
Raymond James Financial Inc Shares Held: 982K ($389M)
Q4 2024
Principal Financial Group Inc Shares Held: 422K ($167M)
Q4 2024
Alecta Tjanstepension Omsesidigt Shares Held: 177K ($69.9M)
Q4 2024
Strategic Financial Concepts, LLC Shares Held: 155K ($61.3M)
Q4 2024
Nordea Investment Management Ab Shares Held: 972K ($385M)

Top Sells

Q4 2024
International Assets Investment Management, LLC Shares Held: 2.58K ($1.02M)
Q4 2024
Greenleaf Trust Shares Held: 17.7M ($7.03B)
Q4 2024
Proficio Capital Partners LLC Shares Held: 1.66K ($656K)
Q4 2024
Sumitomo Mitsui Trust Holdings, Inc. Shares Held: 770K ($305M)
Q4 2024
Fisher Asset Management, LLC Shares Held: 4.08M ($1.62B)

About SYK

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.


Insider Transactions at SYK

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
339K Shares
From 30 Insiders
Grant, award, or other acquisition 89.9K shares
Exercise of conversion of derivative security 249K shares
Bona fide gift 198 shares
Sell / Disposition
946K Shares
From 21 Insiders
Payment of exercise price or tax liability 192K shares
Open market or private sale 739K shares
Bona fide gift 15.3K shares

Track Institutional and Insider Activities on SYK

Follow STRYKER CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYK shares.

Notify only if

Insider Trading

Get notified when an Stryker Corp insider buys or sells SYK shares.

Notify only if

News

Receive news related to STRYKER CORP

Track Activities on SYK